3
Orphan Designations
0
FDA Approvals
7
Rare Diseases
0
News Articles
| Disease | Drug(s) | Designation | Approved |
|---|---|---|---|
| anti-MDA5 dermatomyositis | Cytomegalovirus DNA Vaccine w/Copolymer/Benzalkonium Chloride | Orphan Designation | - |
| clinically amyopathic dermatomyositis | Cytomegalovirus DNA Vaccine w/Copolymer/Benzalkonium Chloride | Orphan Designation | - |
| ductal breast carcinoma in situ and lobular carcinoma in situ | HLA-B7/Beta2M DNA Lipid (DMRIE/DOPE) Complex | Orphan Designation | - |
| endogenous depression | Cytomegalovirus DNA Vaccine w/Copolymer/Benzalkonium Chloride | Orphan Designation | - |
| invasive ductal and lobular carcinoma | HLA-B7/Beta2M DNA Lipid (DMRIE/DOPE) Complex | Orphan Designation | - |
| non-invasive bladder urothelial carcinoma | HLA-B7/Beta2M DNA Lipid (DMRIE/DOPE) Complex | Orphan Designation | - |
| renal cell carcinoma | DNA-lipid complex (DMRIE/DOPE)/plasmid vector (VCL-1102, Vical) expressing human interleukin-2 | Orphan Designation | - |